TachoSil®
Sponsors
Nycomed, Takeda, Medtronic - MITG, University Hospital, Basel, Switzerland, Sealantium Medical Ltd.
Conditions
BleedingCardiac Surgical ProceduresCerebrospinal Fluid LeaksColorectal AnastomosisFibrin SealantGeneral SurgeryHaemostasisHemorrhage
Phase 1
Phase 2
Phase 3
TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection Surgery
CompletedNCT01192022
Start: 2010-08-31End: 2013-05-31Updated: 2015-11-25
TASALL - TachoSil® Against Liquor Leak
CompletedNCT01355627
Start: 2011-04-30End: 2013-06-30Updated: 2014-07-25
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery
CompletedNCT01500135
Start: 2012-03-31End: 2015-12-31Updated: 2017-02-08
Unknown Phase
A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery
CompletedNCT01639833
Start: 2012-08-31End: 2013-12-31Updated: 2014-07-03
Use of Tachosil® for Lymph Sealing During Surgery
CompletedNCT01920958
Start: 2012-09-30End: 2014-03-31Updated: 2016-12-19
Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation
CompletedNCT04065880
Start: 2020-04-01End: 2021-07-31Updated: 2023-05-15
Assessment of Long-term Effects of Tachosil
CompletedNCT05986201
Start: 2016-02-01End: 2023-06-01Updated: 2023-08-14